Regulation for production and use of Medical Cannabis published by Mexican congress.
After years of delay, today the Mexican congress released the Regulation of the General Health Law on Sanitary Control for the Production, Research and Medicinal Use of Cannabis and its Pharmacological Derivatives, published in the Official Journal of the Federation.
Here are some key takeaways:
The law regulates the supply chain of cannabis cultivation, production & manufacturing of raw materials for pharmacological and medicinal uses, as well as scientific research purposes.
The primary governmental agencies charged with overseeing permitting are the COFEPRIS (Federal Commission for the Protection against Sanitary Risks) and the SENASICA (National Service of Agrifood Health, Safety and Quality). Other agencies that have jurisdiction over regulation and oversight include the Ministry of Health, the Ministry of Finance and Public Credit, and the the Secretariat of Agriculture and Rural Development (under which the SENASICA operates).
The COFEPRIS will oversee implementation and administration of a seed-to-sale Tracking & Traceability System that will be of a public nature to ensure transparency and oversight. Other agencies will have authority over parts of the system, such as quality control of seeds through the National Seed Inspection and Certification Service (SNICS ), and oversight of import/export of raw materials and finished products though the Tax Administration Service (SAT).
Lastly, following similar models in the US, a patient registry will exist for any authorized suppliers who vend medicinal cannabis and its derivatives to patients with a valid prescription. Said suppliers are prohibited from marketing cannabis and derived products to the general public, but marketing to health professionals will be allowed (B2B).
See the full publication of the Law here.